Literature DB >> 25144556

Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence.

Izumi Horikawa1, Kaori Fujita2, Lisa M Miller Jenkins3, Yukiharu Hiyoshi4, Abdul M Mondal4, Borivoj Vojtesek5, David P Lane6, Ettore Appella3, Curtis C Harris4.   

Abstract

Δ133p53α, a p53 isoform that can inhibit full-length p53, is downregulated at replicative senescence in a manner independent of mRNA regulation and proteasome-mediated degradation. Here we demonstrate that, unlike full-length p53, Δ133p53α is degraded by autophagy during replicative senescence. Pharmacological inhibition of autophagy restores Δ133p53α expression levels in replicatively senescent fibroblasts, without affecting full-length p53. The siRNA-mediated knockdown of pro-autophagic proteins (ATG5, ATG7 and Beclin-1) also restores Δ133p53α expression. The chaperone-associated E3 ubiquitin ligase STUB1, which is known to regulate autophagy, interacts with Δ133p53α and is downregulated at replicative senescence. The siRNA knockdown of STUB1 in proliferating, early-passage fibroblasts induces the autophagic degradation of Δ133p53α and thereby induces senescence. Upon replicative senescence or STUB1 knockdown, Δ133p53α is recruited to autophagosomes, consistent with its autophagic degradation. This study reveals that STUB1 is an endogenous regulator of Δ133p53α degradation and senescence, and identifies a p53 isoform-specific protein turnover mechanism that orchestrates p53-mediated senescence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144556      PMCID: PMC6662595          DOI: 10.1038/ncomms5706

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  42 in total

1.  Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.

Authors:  Izumi Horikawa; Kye-Yoon Park; Kazunobu Isogaya; Yukiharu Hiyoshi; Han Li; Katsuhiro Anami; Ana I Robles; Abdul M Mondal; Kaori Fujita; Manuel Serrano; Curtis C Harris
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

2.  Autophagy Induces Prosenescent Changes in Proximal Tubular S3 Segments.

Authors:  Arpita Baisantry; Sagar Bhayana; Song Rong; Esther Ermeling; Christoph Wrede; Jan Hegermann; Petra Pennekamp; Inga Sörensen-Zender; Hermann Haller; Anette Melk; Roland Schmitt
Journal:  J Am Soc Nephrol       Date:  2015-10-20       Impact factor: 10.121

3.  p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration.

Authors:  C Turnquist; I Horikawa; E Foran; E O Major; B Vojtesek; D P Lane; X Lu; B T Harris; C C Harris
Journal:  Cell Death Differ       Date:  2016-04-22       Impact factor: 15.828

4.  Δ133p53: A p53 isoform enriched in human pluripotent stem cells.

Authors:  Izumi Horikawa; Curtis C Harris
Journal:  Cell Cycle       Date:  2017-07-20       Impact factor: 4.534

Review 5.  Emerging strategies to effectively target autophagy in cancer.

Authors:  V W Rebecca; R K Amaravadi
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 6.  p53: 800 million years of evolution and 40 years of discovery.

Authors:  Arnold J Levine
Journal:  Nat Rev Cancer       Date:  2020-05-13       Impact factor: 60.716

7.  Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.

Authors:  Jessica Beck; Casmir Turnquist; Izumi Horikawa; Curtis Harris
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

Review 8.  Autophagy in malignant transformation and cancer progression.

Authors:  Lorenzo Galluzzi; Federico Pietrocola; José Manuel Bravo-San Pedro; Ravi K Amaravadi; Eric H Baehrecke; Francesco Cecconi; Patrice Codogno; Jayanta Debnath; David A Gewirtz; Vassiliki Karantza; Alec Kimmelman; Sharad Kumar; Beth Levine; Maria Chiara Maiuri; Seamus J Martin; Josef Penninger; Mauro Piacentini; David C Rubinsztein; Hans-Uwe Simon; Anne Simonsen; Andrew M Thorburn; Guillermo Velasco; Kevin M Ryan; Guido Kroemer
Journal:  EMBO J       Date:  2015-02-23       Impact factor: 11.598

Review 9.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

Review 10.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.